Research Archive — Page 74 of 137
-
June 21, 2021
Dexmedetomidine and delirium
The sedative dexmedetomidine, when administered during or after heart surgery, is associated with postoperative delirium and adverse outcomes. -
June 17, 2021
COVID-19 complication underdiagnosed
A mysterious inflammatory syndrome linked to COVID-19 infection and first identified in children also occurs in adults, Vanderbilt researchers report. -
June 17, 2021
Drug allergy labels in medical records power searches for gene-drug associations
-
June 17, 2021
New neurodegeneration culprit
A young woman with a puzzling neurological illness and novel genetic variant pointed investigators to a role for dysregulated protein kinase D1 in neurodegeneration. -
June 8, 2021
VUMC team develops potential treatment for life-threatening microbial inflammation
A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections. -
June 3, 2021
‘Secret shopper’ study sheds light on barriers to opioid treatment for women
After a 2020 Vanderbilt University Medical Center study showed women have a difficult time accessing treatment for opioid use disorder (OUD), investigators analyzed comments received from the study’s participants to further shed light on barriers to care, which included everything from long on-hold times to difficult interactions with clinic receptionists during phone calls seeking appointments. -
June 3, 2021
VUMC team discovers new genetic disease
Researchers at Vanderbilt University Medical Center have discovered a new genetic disease that causes a severe form of neurogenic orthostatic hypotension, a rapid drop in blood pressure upon standing that can cause fainting.